Joshua Dennerlein
Stock Analyst at B of A Securities
(1.72)
# 3,301
Out of 5,182 analysts
90
Total ratings
42.86%
Success rate
-3.56%
Average return
Main Sectors:
Stocks Rated by Joshua Dennerlein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OHI Omega Healthcare Investors | Downgrades: Underperform | $52 → $46 | $47.19 | -2.52% | 12 | Apr 14, 2026 | |
| TRI Thomson Reuters | Maintains: Neutral | $103 → $119 | $92.94 | +27.64% | 2 | Mar 10, 2026 | |
| CPT Camden Property Trust | Maintains: Buy | $142 → $137 | $103.77 | +32.02% | 5 | Nov 12, 2025 | |
| LINE Lineage | Downgrades: Underperform | $47 → $42 | $39.96 | +5.11% | 2 | Aug 11, 2025 | |
| NTST NETSTREIT | Upgrades: Neutral | $18 → $19 | $20.67 | -8.08% | 3 | Jul 28, 2025 | |
| FVR FrontView REIT | Downgrades: Underperform | $15 → $11 | $18.17 | -39.46% | 2 | Jun 17, 2025 | |
| SUI Sun Communities | Maintains: Underperform | $124 → $132 | $125.94 | +4.81% | 3 | May 12, 2025 | |
| CTAS Cintas | Reinstates: Buy | $250 | $166.97 | +49.73% | 1 | Apr 10, 2025 | |
| MSCI MSCI Inc. | Initiates: Neutral | $585 | $585.42 | -0.07% | 1 | Apr 10, 2025 | |
| VRSK Verisk Analytics | Reinstates: Underperform | $280 | $171.87 | +62.91% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $221 → $242 | $214.63 | +12.75% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $34 | $33.02 | +2.97% | 3 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $31 | $51.71 | -40.05% | 2 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $92 | $75.26 | +22.24% | 1 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $307 → $321 | $263.55 | +21.80% | 3 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $144 → $189 | $129.31 | +46.16% | 3 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $45 → $40 | $58.28 | -31.37% | 4 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $18 → $25 | $19.64 | +27.29% | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $53 | $87.26 | -39.26% | 9 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 → $6 | $11.02 | -45.55% | 1 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $42 → $33 | $36.91 | -10.59% | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $52 | $61.92 | -16.02% | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $20.75 | - | 4 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $67 → $54 | $74.10 | -27.13% | 4 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $34 | $14.84 | +125.74% | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $31.40 | - | 4 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 → $78 | $76.22 | +2.34% | 2 | Jun 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $47 | $44.36 | +5.95% | 2 | Jan 20, 2022 |
Omega Healthcare Investors
Apr 14, 2026
Downgrades: Underperform
Price Target: $52 → $46
Current: $47.19
Upside: -2.52%
Thomson Reuters
Mar 10, 2026
Maintains: Neutral
Price Target: $103 → $119
Current: $92.94
Upside: +27.64%
Camden Property Trust
Nov 12, 2025
Maintains: Buy
Price Target: $142 → $137
Current: $103.77
Upside: +32.02%
Lineage
Aug 11, 2025
Downgrades: Underperform
Price Target: $47 → $42
Current: $39.96
Upside: +5.11%
NETSTREIT
Jul 28, 2025
Upgrades: Neutral
Price Target: $18 → $19
Current: $20.67
Upside: -8.08%
FrontView REIT
Jun 17, 2025
Downgrades: Underperform
Price Target: $15 → $11
Current: $18.17
Upside: -39.46%
Sun Communities
May 12, 2025
Maintains: Underperform
Price Target: $124 → $132
Current: $125.94
Upside: +4.81%
Cintas
Apr 10, 2025
Reinstates: Buy
Price Target: $250
Current: $166.97
Upside: +49.73%
MSCI Inc.
Apr 10, 2025
Initiates: Neutral
Price Target: $585
Current: $585.42
Upside: -0.07%
Verisk Analytics
Apr 10, 2025
Reinstates: Underperform
Price Target: $280
Current: $171.87
Upside: +62.91%
Feb 18, 2025
Maintains: Buy
Price Target: $221 → $242
Current: $214.63
Upside: +12.75%
Oct 21, 2024
Upgrades: Buy
Price Target: $31 → $34
Current: $33.02
Upside: +2.97%
Sep 24, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $51.71
Upside: -40.05%
Sep 24, 2024
Initiates: Buy
Price Target: $92
Current: $75.26
Upside: +22.24%
Sep 24, 2024
Downgrades: Neutral
Price Target: $307 → $321
Current: $263.55
Upside: +21.80%
Aug 12, 2024
Upgrades: Buy
Price Target: $144 → $189
Current: $129.31
Upside: +46.16%
May 20, 2024
Downgrades: Underperform
Price Target: $45 → $40
Current: $58.28
Upside: -31.37%
Apr 1, 2024
Upgrades: Buy
Price Target: $18 → $25
Current: $19.64
Upside: +27.29%
Jan 16, 2024
Upgrades: Buy
Price Target: $48 → $53
Current: $87.26
Upside: -39.26%
Nov 7, 2023
Downgrades: Underperform
Price Target: $18 → $6
Current: $11.02
Upside: -45.55%
Oct 31, 2023
Downgrades: Neutral
Price Target: $42 → $33
Current: $36.91
Upside: -10.59%
Oct 10, 2023
Downgrades: Neutral
Price Target: $52
Current: $61.92
Upside: -16.02%
Oct 10, 2023
Upgrades: Buy
Price Target: n/a
Current: $20.75
Upside: -
Sep 26, 2023
Maintains: Underperform
Price Target: $67 → $54
Current: $74.10
Upside: -27.13%
Nov 14, 2022
Upgrades: Buy
Price Target: $28 → $34
Current: $14.84
Upside: +125.74%
Aug 24, 2022
Upgrades: Buy
Price Target: n/a
Current: $31.40
Upside: -
Jun 2, 2022
Upgrades: Buy
Price Target: $76 → $78
Current: $76.22
Upside: +2.34%
Jan 20, 2022
Downgrades: Underperform
Price Target: $52 → $47
Current: $44.36
Upside: +5.95%